Personalized pediatric anesthesia and pain management: problem-based review

Pharmacogenomics. 2020 Jan;21(1):55-73. doi: 10.2217/pgs-2019-0108.

Abstract

Pharmacogenetics, the genetic influence on the interpersonal variability in drug response, has enabled tailored pharmacotherapy and emerging 'personalized medicine.' Although oncology spearheaded the clinical implementation of personalized medicine, other specialties are rapidly catching up. In anesthesia, classical examples of genetically mediated idiosyncratic reactions have been long known (e.g., malignant hyperthermia and prolonged apnea after succinylcholine). The last two decades have witnessed an expanding body of pharmacogenetic evidence in anesthesia. This review highlights some of the prominent pharmacogenetic associations studied in anesthesia and pain management, with special focus on pediatric anesthesia.

Keywords: anesthesia; opioids; pain medicine; pediatric anesthesia; personalized medicine; pharmacogenetics.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anesthesia / methods*
  • Anesthesiology / trends
  • Apnea / chemically induced
  • Apnea / genetics
  • Apnea / pathology
  • Child
  • Child, Preschool
  • Humans
  • Malignant Hyperthermia / etiology
  • Malignant Hyperthermia / genetics
  • Malignant Hyperthermia / pathology
  • Pain / drug therapy*
  • Pain / genetics
  • Pain / pathology
  • Pain Management / methods*
  • Pediatrics
  • Precision Medicine
  • Succinylcholine / adverse effects
  • Succinylcholine / therapeutic use*

Substances

  • Succinylcholine